This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

China denies Pakistan's ties with US behind rare-earth export curbs

( October 14, 2025, 04:05 GMT | Official Statement) -- MLex Summary: Chinese Foreign Ministry spokesman Lin Jian denied that Pakistan’s dealings with the US were behind Beijing’s recent tightening of export controls on rare-earth technology, saying China and Pakistan remain strategic partners. Media reports have said Pakistan exported rare earths to the US using Chinese equipment and technology, prompting Beijing to impose stricter rules on the exports. Lin said Beijing and Islamabad have been in communication over Pakistan’s mining cooperation with Washington, and that Pakistan has pledged its engagement with the US wouldn’t come at the expense of China’s interests or its cooperation with Beijing. He added that the minerals Pakistani leaders showed and presented to their US counterparts were rough gemstone samples purchased by staff. The excerpt of the statement follows: ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections